The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?

M.H.A. Muskiet, M.M. Smits, L.M. Morsink, M. Diamant

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)88-103
JournalNature Reviews Nephrology
Volume10
Issue number2
DOIs
Publication statusPublished - 2014

Cite this

@article{99984d420d404e4a933ecb500045e554,
title = "The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?",
author = "M.H.A. Muskiet and M.M. Smits and L.M. Morsink and M. Diamant",
year = "2014",
doi = "10.1038/nrneph.2013.272",
language = "Undefined/Unknown",
volume = "10",
pages = "88--103",
journal = "Nature Reviews Nephrology",
issn = "1759-5061",
publisher = "Nature Publishing Group",
number = "2",

}

The gut-renal axis: do incretin-based agents confer renoprotection in diabetes? / Muskiet, M.H.A.; Smits, M.M.; Morsink, L.M.; Diamant, M.

In: Nature Reviews Nephrology, Vol. 10, No. 2, 2014, p. 88-103.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - The gut-renal axis: do incretin-based agents confer renoprotection in diabetes?

AU - Muskiet, M.H.A.

AU - Smits, M.M.

AU - Morsink, L.M.

AU - Diamant, M.

PY - 2014

Y1 - 2014

U2 - 10.1038/nrneph.2013.272

DO - 10.1038/nrneph.2013.272

M3 - Article

VL - 10

SP - 88

EP - 103

JO - Nature Reviews Nephrology

JF - Nature Reviews Nephrology

SN - 1759-5061

IS - 2

ER -